StockNews.com Begins Coverage on China Pharma (NYSE:CPHI)

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI) in a research report sent to investors on Friday. The brokerage issued a hold rating on the stock.

China Pharma Price Performance

NYSE:CPHI opened at $0.36 on Friday. The firm’s fifty day moving average is $0.40 and its two-hundred day moving average is $0.49. The company has a quick ratio of 0.33, a current ratio of 0.88 and a debt-to-equity ratio of 0.19. China Pharma has a one year low of $0.32 and a one year high of $2.70.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.